+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Hearing Loss Disease Treatment Market by Product, Disease Type, End User, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717250
The hearing loss disease treatment market size is estimated to be USD 12.84 billion in 2022 and is expected to witness a CAGR of 4.97% during the forecast period 2023-2033. Strong R&D efforts and technological improvement in hearing aid devices are some of the factors contributing to the market growth. Furthermore, increasing rate of hearing loss and expanding public awareness of the condition are other factors supporting the market. However, inadequate reimbursement infrastructure in low- and middle-income nations is expected to hinder the growth.

Strong R&D efforts is expected to fuel the market growth during the projected period. Strong R&D efforts have resulted in the availability of reliable pharmaceuticals in the clinical pipeline that can fill an unmet market need. For instance, a phase 3 clinical trial for Sensorion's SENS-401, which is indicated for severe and abrupt sensorineural hearing loss will begin in January 2022. Ebselen a drug from Sound Pharmaceuticals that is being studied for the treatment of Meniere's Disease, a rare inner ear disorder, will enter phase 3 research in December 2022.

Technological improvement in hearing aid devices is expected to propel the market growth during the forecast period. According to the WHO, untreated hearing loss costs an estimated USD 980 billion yearly globally. This includes the expenses to the health sector, society as a whole, lost production, and support expenditures for schooling. 57% of this expense was borne by countries with low and moderate incomes. As a result, these innovative features and technological advancements are enhancing patient experiences which is expected to accelerate market growth over the coming years.

Segmentation

By Product

The market is segmented into drugs and devices. In 2022, the segment accounted for the highest revenue share due to the fact that auditory devices are complex, introduction of new products with advanced capabilities, unavailability of FDA-approved medications for the treatment of hearing loss, and presence of payers operating in this market. A cochlear implant can help patients with serious medical issues. Even if one ear is impacted by severe listening impairment while the other ear has a normal/mild/moderate hearing condition, persons can maintain the same audio quality due to advancements in cochlear implants. The growth of the market is being fueled by such device advancements. The drugs segment is anticipated to experience the fastest CAGR throughout the forecast period due to the introduction of new therapeutic treatments. There are drugs available for a number of hearing issues. This covers common therapies including steroid injections for acute hearing loss or inflammation and medicines for ear infections. As a result, the industry has benefited from significant growth potential due to the demand for new and focused treatment solutions.

By Disease Type

The market is categorized into sensorineural hearing loss, conductive hearing loss, and mixed. In the global market, the sensorineural hearing loss segment accounted for the largest revenue share in 2022 owing to most prevalent disease shown in patients and the expansion of available treatments. Other significant risk factors for sensorineural hearing loss include increase in exposure to loud noises, viral or bacterial infections, cancers, and autoimmune inner ear diseases. A study by Johns Hopkins Medicine found that 30% of persons 65 and older have some degree of age-related hearing impairment. Furthermore, according to the National Institute on Deafness and Other Communication Disorders (NIDCD), 1 in 3 Americans between the ages of 65 and 75 suffer from hearing loss. Thus, the disease's rising incidence is fueling the segment's expansion. Additionally, there is a large chance for market expansion due to the expanding research and development for better space-based treatment choices. For instance, phase 3 clinical research involving Sensorion's SENS-401. Additionally, severe cases of irreversible sensorineural hearing loss require cochlear implants or the use of hearing aids.

By End User

The market is segmented into ambulatory clinics, hospitals, and otology clinics. In 2022, the segment accounted for the largest revenue share owing to rising need for multispecialty institutions to treat these disorders. A multidisciplinary group of specialists with specialised training in both medicine and surgery treat patients who complain of ear issues. For patients with ear infections, hearing loss, and tumours affecting both the ear and the skull, for instance, otologists and neurotologists can work together efficiently. The segment is expanding as consumers have access to a variety of services such counselling, medical and surgical treatment, rehabilitation, and post-operative care at hospitals. Hospitals also provide services and are devoted to educating, teaching, and counselling patients and their families with medicine and condition post-management. As a result of efforts made in automating the process of collecting information from medical and pharmacy insurance providers, payers and patients can now clear claims rapidly and easily, creating profitable potential for market expansion.

Regional Markets

In 2022, North America region accounted for the highest revenue in the hearing loss disease treatment market and is expected to maintain its dominance during the forecast period. This is attributed to the increasing frequency of diseases, existence of important companies, and the U.S.'s high purchasing power for branded pharmaceuticals and advanced equipment. For instance, in September 2022, the FDA approved PEDMARK from Fennec Pharmaceuticals Inc. to decrease the hearing loss caused by cisplatin chemotherapy in children. Additionally, number of groups organize awareness campaigns on World Hearing Day to increase awareness of disability. However, the Asia Pacific area is anticipated to experience the fastest growth as a result of the expanding number of target patients and funding provided to significant regional players.

Competitor Insights

Some of the key players operating in the hearing loss disease treatment market are Audina Hearing Instruments, Inc., Sensorion, Pipeline Therapeutics, Acousia Therapeutics GmbH, Frequency Therapeutics, Astellas Pharma, Inc., Otonomy, Inc., WS Audiology A/S, Novartis, and audifon GmbH & Co. KG.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, Astellas Pharma Inc. and Mogrify Ltd. declared a research collaboration agreement in July 2022 to develop regenerative therapeutics to treat sensorineural hearing loss. Top genetic medicine experts from Astella will be engaged with working on AVV-based genetics as part of this collaboration.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, disease type, and end user from 2023 to 2033.

Segmentation: Hearing Loss Disease Treatment Market Report 2022 - 2033

Product (Revenue, USD Million), 2022 - 2033

Drugs

  • Antiviral medication
  • Systemic Steroids
  • Vasodilators
  • Others
  • Devices

Disease Type (Revenue, USD Million), 2022 - 2033

  • Sensorineural Hearing Loss
  • Conductive Hearing Loss
  • Mixed

End user (Revenue, USD Million), 2022 - 2033

  • Ambulatory Clinics
  • Hospitals
  • Otology Clinics

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Disease Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Disease Model

2. Introduction: Hearing Loss Disease Treatment

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Hearing Loss Disease Treatment Market

7. Market Analysis by Product
7.1. Drugs
7.1.1. Drugs Market Forecast, 2022-2033 (USD Billion)
7.1.1.1. Antiviral medication
7.1.1.1.1. Antiviral medication Market Forecast, 2022-2033 (USD Million)
7.1.1.2. Systemic Steroids
7.1.1.2.1. Systemic Steroids Market Forecast, 2022-2033 (USD Million)
7.1.1.3. Vasodilators
7.1.1.3.1. Vasodilators Market Forecast, 2022-2033 (USD Million)
7.1.1.4. Others
7.1.1.4.1. Others Market Forecast, 2022-2033 (USD Million)
7.2. Devices
7.2.1. Devices Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Disease Type
8.1. Sensorineural Hearing Loss
8.1.1. Sensorineural Hearing Loss Market Forecast, 2022-2033 (USD Million)
8.2. Conductive Hearing Loss
8.2.1. Conductive Hearing Loss Market Forecast, 2022-2033 (USD Million)
8.3. Mixed
8.3.1. Mixed Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by End User
9.1. Ambulatory Clinics
9.1.1. Ambulatory Clinics Market Forecast, 2022-2033 (USD Million)
9.2. Hospitals
9.2.1. Hospitals Market Forecast, 2022-2033 (USD Million)
9.3. Otology Clinics
9.3.1. Otology Clinics Market Forecast, 2022-2033 (USD Million)

8. Regional Market Analysis
8.1. Regional Market Trends Analysis

9. North America Hearing Loss Disease Treatment Market
9.1. North America Hearing Loss Disease Treatment Market
9.1.1. North America Market Size and Forecast, 2022-2033 (USD Billion)
9.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
9.1.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
9.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
9.2. U.S. Hearing Loss Disease Treatment Market
9.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Billion)
9.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
9.2.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
9.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
9.3. Canada Hearing Loss Disease Treatment Market
9.3.1. Canada Market Size and Forecast, 2022-2033 (USD Billion)
9.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
9.3.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
9.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)

10. Europe Hearing Loss Disease Treatment Market
10.1. Europe Hearing Loss Disease Treatment Market
10.1.1. Europe Market Size and Forecast, 2022-2033 (USD Billion)
10.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
10.1.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
10.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
10.2. Germany Hearing Loss Disease Treatment Market
10.2.1. Germany Market Size and Forecast, 2022-2033 (USD Billion)
10.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
10.2.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
10.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
10.3. UK Hearing Loss Disease Treatment Market
10.3.1. UK Market Size and Forecast, 2022-2033 (USD Billion)
10.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
10.3.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
10.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
10.4. France Hearing Loss Disease Treatment Market
10.4.1. France Market Size and Forecast, 2022-2033 (USD Billion)
10.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
10.4.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
10.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
10.5. Spain Hearing Loss Disease Treatment Market
10.5.1. Spain Market Size and Forecast, 2022-2033 (USD Billion)
10.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
10.5.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
10.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
10.6. Italy Hearing Loss Disease Treatment Market
10.6.1. Italy Market Size and Forecast, 2022-2033 (USD Billion)
10.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
10.6.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
10.6.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
10.7. Rest of Europe Hearing Loss Disease Treatment Market
10.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Billion)
10.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
10.7.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
10.7.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)

11. Asia Pacific Hearing Loss Disease Treatment Market
11.1. Asia Pacific Hearing Loss Disease Treatment Market
11.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Billion)
11.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
11.1.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
11.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
11.2. Japan Hearing Loss Disease Treatment Market
11.2.1. Japan Market Size and Forecast, 2022-2033 (USD Billion)
11.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
11.2.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
11.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
11.3. China Hearing Loss Disease Treatment Market
11.3.1. China Market Size and Forecast, 2022-2033 (USD Billion)
11.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
11.3.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
11.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
11.4. India Hearing Loss Disease Treatment Market
11.4.1. India Market Size and Forecast, 2022-2033 (USD Billion)
11.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
11.4.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
11.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
11.5. South Korea Hearing Loss Disease Treatment Market
11.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Billion)
11.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
11.5.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
11.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
11.6. Australia Hearing Loss Disease Treatment Market
11.6.1. Australia Market Size and Forecast, 2022-2033 (USD Billion)
11.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
11.6.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
11.6.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
11.7. Rest of Asia Pacific Hearing Loss Disease Treatment Market
11.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Billion)
11.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
11.7.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
11.7.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)

12. Latin America Hearing Loss Disease Treatment Market
12.1. Latin America Hearing Loss Disease Treatment Market
12.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Billion)
12.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
12.1.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
12.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
12.2. Brazil Hearing Loss Disease Treatment Market
12.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Billion)
12.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
12.2.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
12.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
12.3. Mexico Hearing Loss Disease Treatment Market
12.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Billion)
12.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
12.3.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
12.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
12.4. Argentina Hearing Loss Disease Treatment Market
12.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Billion)
12.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
12.4.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
12.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
12.5. Rest of Latin America Hearing Loss Disease Treatment Market
12.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Billion)
12.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
12.5.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
12.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)

13. MEA Hearing Loss Disease Treatment Market
13.1. MEA Hearing Loss Disease Treatment Market
13.1.1. MEA Market Size and Forecast, 2022-2033 (USD Billion)
13.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
13.1.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
13.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
13.2. GCC Hearing Loss Disease Treatment Market
13.2.1. GCC Market Size and Forecast, 2022-2033 (USD Billion)
13.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
13.2.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
13.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
13.3. South Africa Hearing Loss Disease Treatment Market
13.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Billion)
13.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
13.3.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
13.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)
13.4. Rest of MEA Hearing Loss Disease Treatment Market
13.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Billion)
13.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Billion)
13.4.1.2. Market Size and Forecast by Disease Type, 2022-2033 (USD Billion)
13.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Billion)

14. Competitor Analysis
14.1. Market Share Analysis, 2022
14.2. Major Recent Developments, 2019-2022

15. Company Profiles
15.1. Audina Hearing Instruments, Inc.
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Analysis
15.1.4. Product Benchmarking
15.1.5. Recent Developments
15.2. Sensorion
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Analysis
15.2.4. Product Benchmarking
15.2.5. Recent Developments
15.3. Pipeline Therapeutics
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Analysis
15.3.4. Product Benchmarking
15.3.5. Recent Developments
15.4. Acousia Therapeutics GmbH
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Analysis
15.4.4. Product Benchmarking
15.4.5. Recent Developments
15.5. Frequency Therapeutics
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Analysis
15.5.4. Product Benchmarking
15.5.5. Recent Developments
15.6. Astellas Pharma, Inc.
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Analysis
15.6.4. Product Benchmarking
15.6.5. Recent Developments
15.7. Otonomy, Inc.
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Analysis
15.7.4. Product Benchmarking
15.7.5. Recent Developments
15.8. WS Audiology A/S
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Analysis
15.8.4. Product Benchmarking
15.8.5. Recent Developments
15.9. Novartis
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Analysis
15.9.4. Product Benchmarking
15.9.5. Recent Developments
15.10. audifon GmbH & Co. KG
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Analysis
15.10.4. Product Benchmarking
15.10.5. Recent Developments
15.11. Company 11
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financial Analysis
15.11.4. Product Benchmarking
15.11.5. Recent Developments
15.12. Company 12
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financial Analysis
15.12.4. Product Benchmarking
15.12.5. Recent Developments
15.13. Company 13
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financial Analysis
15.13.4. Product Benchmarking
15.13.5. Recent Developments
15.14. Company 14
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financial Analysis
15.14.4. Product Benchmarking
15.14.5. Recent Developments
15.15. Company 15
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financial Analysis
15.15.4. Product Benchmarking
15.15.5. Recent Developments

16. Conclusion

17. Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Audina Hearing Instruments Inc.
  • Sensorion
  • Pipeline Therapeutics
  • Acousia Therapeutics GmbH
  • Frequency Therapeutics
  • Astellas Pharma Inc.
  • Otonomy Inc.
  • WS Audiology A/S
  • Novartis
  • audifon GmbH & Co. KG.